Soframycin Maker Encube Ethicals Seeks ₹3,000 Cr in Upcoming Public Issue.
Mumbai-based Encube Ethicals has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI)
Read MoreMumbai-based Encube Ethicals has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI)
Read MoreThe markets commenced the week positively, with benchmark indices continuing their upward momentum, buoyed by declining crude oil prices and
Read MoreMarket participants experienced a significant shock during the inaugural trading session of the new auction system at the exchanges, leading
Read MoreAluminum prices have witnessed a significant increase following missile attacks on two major Middle Eastern producers over the weekend, specifically
Read MoreZepto Ltd.’s recent setbacks in its initial public offering (IPO) plans reflect a significant recalibration of market expectations and investor
Read MoreThe recent Assembly bypolls have proven to be a mixed bag for the Bharatiya Janata Party (BJP), with the party’s
Read MoreSpaceX’s forthcoming earnings report, marking its first since the significant IPO valued at $86 billion, is poised to be a
Read MoreThe recent increase in wholesale price inflation (WPI) to 9.87% in June has raised concerns among economists and policymakers. This
Read MoreThe H. R. Hygiene Products SME IPO is set to open for subscription on July 29, 2026, aiming to raise
Read MoreNexus Select Trust has demonstrated a solid performance for the quarter ending June, with an 11% year-on-year increase in net
Read More